BullFrog AI Holdings (BFRGW) Non-Current Assets (2022 - 2026)
BullFrog AI Holdings' (BFRGW) quarterly Non-Current Assets came in at $223332.0 in Q2 2026, up 33.95% on a YoY basis from $166722.0 in Q2 2025, and little changed quarter-over-quarter from $224195.0 in Q4 2025.
Powered by 
Analysis
BullFrog AI Holdings (BFRGW) Non-Current Assets (2022 - 2026) Analysis & Trends
BullFrog AI Holdings (BFRGW) has reported Non-Current Assets for 5 consecutive years, with $223332.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Non-Current Assets rose 33.95% year-over-year to $223332.0; the trailing twelve-month figure through Jun 2026 stood at $780540.0 (up 334.91% YoY), and the FY2025 full-year result was $224195.0, up 5175.18% from the prior year.
- Non-Current Assets held at $223332.0 in Q2 2026 per BFRGW's latest filing, from $224195.0 in the prior quarter.
- Across five years, Non-Current Assets topped out at $224195.0 in Q4 2025 and bottomed at $3818.0 in Q1 2025.
- Historically, Non-Current Assets has averaged $59866.3 across 5 years, with a median of $6621.5 in 2023.
- The widest YoY moves for Non-Current Assets: up 5175.18% in 2025, down 31.12% in 2025.
- Over 5 years, Non-Current Assets stood at $7699.0 in 2022, then fell by 22.41% to $5974.0 in 2023, then slipped by 28.86% to $4250.0 in 2024, then surged by 5175.18% to $224195.0 in 2025, then slipped by 0.38% to $223332.0 in 2026.
- According to Business Quant data, Non-Current Assets over the past three periods registered $223332.0, $224195.0, and $166291.0 for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.54 Bn | 197.55 Bn | 7.24 Bn | 60.68 Bn |
| 2 | Gilead Sciences | 181.14 Bn | 177.96 Bn | 6.22 Bn | 35.42 Bn |
| 3 | Vertex Pharmaceuticals | 132.38 Bn | 124.53 Bn | 2.84 Bn | 14.88 Bn |
| 4 | Regeneron Pharmaceuticals | 82.86 Bn | 74.87 Bn | 3.93 Bn | 23.28 Bn |
| 5 | Argenx Se | 61.69 Bn | 56.51 Bn | 1.37 Bn | 1.96 Bn |
| 6 | Moderna | 54.27 Bn | 49.13 Bn | 52.00 Mn | 5.15 Bn |
| 7 | Alnylam Pharmaceuticals | 34.28 Bn | 30.98 Bn | 992.69 Mn | 938.60 Mn |
| 8 | Biogen | 31.25 Bn | 29.97 Bn | 1.96 Bn | 24.78 Bn |
| 9 | Roivant Sciences | 30.10 Bn | 30.10 Bn | 1.16 Mn | 564.41 Mn |
| 10 | BullFrog AI Holdings | 1.84 Mn | -5.08 Mn | 106,899.00 | 223,332.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 223,332.00 |
| Dec 31, 2025 | 224,195.00 |
| Sep 30, 2025 | 166,291.00 |
| Jun 30, 2025 | 166,722.00 |
| Mar 31, 2025 | 3,818.00 |
| Dec 31, 2024 | 4,250.00 |
| Sep 30, 2024 | 4,681.00 |
| Jun 30, 2024 | 5,112.00 |
| Mar 31, 2024 | 5,543.00 |
| Dec 31, 2023 | 5,974.00 |
| Sep 30, 2023 | 6,406.00 |
| Jun 30, 2023 | 6,837.00 |
| Mar 31, 2023 | 7,268.00 |
| Dec 31, 2022 | 7,699.00 |